News About: Pharm. Industry
CGBio starts first clinical trial for next-generation stent for coronary artery
CGBio(CEO Hyun-Seung Yoo) announced after the Ministry of Food and Drug Safety(MOHW) approved the clinical trial plan of drug-eluting stent for coronary artery, Professor Hyo-Soo Kim’s research team at Seoul National ...
5 pharmas including Yuhan Corporation spent KRW 30 billion advertising expenses last year
A company which spent the most into advertising last year was Yuhan Corporation with KRW 51.3 billion, and there were the total 4 pharmaceutical companies that invested more than KRW 30 billion advertising expenses in...
Kwang Dong made registration of patent with Kyungokko in Japan for prevention and treatment of male infertility
Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 21st that Kyungokko KwangDong, which has been exported to Japan, registered a patent(No. JP6063499, expiring on Feb 27 2035) at the Japan Patent Office as ...
‘Novartis rebate trial’ with no progress
The trial, which has drawn attention since a former Novartis executive who admitted provision of rebates decided to attend as a witness, did not even get started with the witness examination.
The Criminal Investigati...
Green Cross wins contract to supply the largest flu vaccines with collective supply of USD 200 million
Green Cross made the largest flu vaccine exports ever.
Green Cross(CEO Eun-Cheol Huh) announced on the 20th that the company won a contract to supply flu vaccines of approx. USD 37 million(KRW 41 billion) at the bid ...
Listed pharmas stingy with contributions to the society, donating 0.15% of sales
Among listed pharmaceutical companies, Kwang Dong Pharmaceutical and Korea United Pharm spent donations more than KRW 3 billion last year.
There were, on the other hand, 6 pharmaceutical companies which spent less th...
KPBMA & KRPIA raised one voice for growth of pharmaceutical industry
Korea Pharmaceutical and Bio-Pharma Manufacturers Association(KPBMA) Chairman Hee-Mok Won and Korea Research-based Pharma Industry Association(KRPIA) Chair Oak-Yeon Kim had a breakfast meeting at Sheraton Seoul Palace...
Listed pharmas take 109 days on average to collect trade receivables after selling drugs
It took 109 days on average for listed pharmaceutical companies to collect payments after selling pharmaceutical products.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed p...
Boryung Pharm & Lilly sign marketing and partnership agreements of Prozac and Strattera
On the 15th, Boryung Pharm(CEO Tae-Hong Choi) and Lilly Korea(CEO Paul Henry Huibers) signed a marketing and partnership agreement of the antidepressant Prozac(generic name: fluoxetine) and the attention-deficit/hyper...
MSD Korea will supply the hepatitis C treatment Zepatier in Korean market
MSD Korea(CEO Avi BenShoshan) announced the launch of its own chronic hepatitis C treatment Zepatier™ (generic name: elbasvir/grazoprevir) on the 16th.
With the launch, Zepatier, a drug for the treatment of genotype ...
